Precedex and Le test abnormal - a phase IV clinical study of FDA data
Summary:
We study 1,019 people who take Precedex (dexmedetomidine) or have Le test abnormal. No report of Le test abnormal is found in people who take Precedex.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
What is Precedex?
Precedex has active ingredients of dexmedetomidine. eHealthMe is studying from 1,007 Precedex users. Check the latest studies of Precedex.
What is Le Test Abnormal?
Le test abnormal is found to be associated with 2 drugs by eHealthMe. Check the latest studies of Le test abnormal.
No report is found.
Do you take Precedex and have Le test abnormal?
- Check whether Le test abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Precedex:
- Precedex (1,007 reports)
Le test abnormal treatments and more:
- Le test abnormal (12 reports)
How severe was Le test abnormal and when was it recovered:
Expand to all the drugs that have ingredients of dexmedetomidine:
Browse all side effects of Precedex:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Le test abnormal:
Browse all the conditions that are associated with Le test abnormal:
How the study uses the data?
The study uses data from the FDA. It is based on dexmedetomidine (the active ingredients of Precedex) and Precedex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Gemcitabine and Warfarin Sodium - a second ago
- Could Actonel cause Mental Status Changes? - a second ago
- Erection Problems and drugs of ingredients of amlodipine besylate - 3 seconds ago
- Allergy To Vaccine and drugs of ingredients of cyclobenzaprine hydrochloride - 7 seconds ago
- Drug interactions of Noxafil and Pravastatin Sodium - 8 seconds ago
- Could Dexamethasone Acetate cause High Blood Pressure? - 9 seconds ago
- Syphilis and Back Pain - 11 seconds ago
- Could Morphine Sulfate cause Acarodermatitis? - 12 seconds ago
- Pain Exacerbated in Topiramate, how severe and when it was recovered? - 13 seconds ago
- Could Alphagan cause Sciatica Aggravated? - 22 seconds ago